Literature DB >> 8816482

Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype.

R Moriggl1, V Gouilleux-Gruart, R Jähne, S Berchtold, C Gartmann, X Liu, L Hennighausen, A Sotiropoulos, B Groner, F Gouilleux.   

Abstract

The Stat (signal transducer and activator of transcription) factors transmit cytokine, growth factor, and hormone responses. Seven members of the Stat gene family are known. MGF-Stat5a has been discovered as a mediator of the prolactin response in mammary epithelial cells. Two closely related variants of Stat5, Stat5a and Stat5b, are encoded by distinct genes. We examined the functional properties of the carboxyl termini of these molecules. Wild-type Stat5a (794 amino acids) and the carboxyl-terminal deletion mutant Stat5a delta 772 supported prolactin-induced transcription of a beta-casein promoter-reporter construct in COS7 cells; Stat5a delta 750 did not. Upon prolactin activation, tyrosine phosphorylation and the specificity of DNA binding were indistinguishable among the three Stat5a variants. Tyrosine dephosphorylation and the downregulation of the DNA-binding activity were delayed in the Stat5a delta 750 mutant. The carboxyl-terminal transactivation domain of Stat5a, amino acids 722 to 794, can be conferred to the DNA-binding domain of the yeast transcription factor GAL4. Coexpression of Stat5a or Stat5b and of the carboxyl-terminal deletion mutants resulted in the suppression of transcriptional induction in COS or Ba/F3 cells. We propose that Stat5a delta 750 and Stat5b delta 754 are lacking functional transactivation domains and exert their dominant negative effects by blocking the DNA-binding site in Stat5-responsive gene promoters.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8816482      PMCID: PMC231569          DOI: 10.1128/MCB.16.10.5691

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation.

Authors:  Z Wen; Z Zhong; J E Darnell
Journal:  Cell       Date:  1995-07-28       Impact factor: 41.582

Review 2.  Transcriptional responses to polypeptide ligands: the JAK-STAT pathway.

Authors:  C Schindler; J E Darnell
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

3.  Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3.

Authors:  T S Schaefer; L K Sanders; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

4.  Identification of a variable region within the cytoplasmic tail of the IL-2 receptor beta chain that is required for growth signal transduction.

Authors:  K D Liu; S Y Lai; M A Goldsmith; W C Greene
Journal:  J Biol Chem       Date:  1995-09-22       Impact factor: 5.157

5.  STAT protein complexes activated by interferon-gamma and gp130 signaling molecules differ in their sequence preferences and transcriptional induction properties.

Authors:  P Lamb; H M Seidel; J Haslam; L Milocco; L V Kessler; R B Stein; J Rosen
Journal:  Nucleic Acids Res       Date:  1995-08-25       Impact factor: 16.971

6.  Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins.

Authors:  M David; E Petricoin; C Benjamin; R Pine; M J Weber; A C Larner
Journal:  Science       Date:  1995-09-22       Impact factor: 47.728

Review 7.  Cytokine receptor signalling.

Authors:  J N Ihle
Journal:  Nature       Date:  1995-10-19       Impact factor: 49.962

8.  Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.

Authors:  J A Johnston; C M Bacon; D S Finbloom; R C Rees; D Kaplan; K Shibuya; J R Ortaldo; S Gupta; Y Q Chen; J D Giri
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

9.  Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue.

Authors:  X Liu; G W Robinson; F Gouilleux; B Groner; L Hennighausen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

10.  Thrombopoietin activates a STAT5-like factor in hematopoietic cells.

Authors:  C Pallard; F Gouilleux; L Bénit; L Cocault; M Souyri; D Levy; B Groner; S Gisselbrecht; I Dusanter-Fourt
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

View more
  54 in total

1.  A small amphipathic alpha-helical region is required for transcriptional activities and proteasome-dependent turnover of the tyrosine-phosphorylated Stat5.

Authors:  D Wang; R Moriggl; D Stravopodis; N Carpino; J C Marine; S Teglund; J Feng; J N Ihle
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

Review 2.  Developing a mammary gland is a stat affair.

Authors:  L Hennighausen; G W Robinson; K U Wagner; X Liu
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

3.  Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation.

Authors:  M Kieslinger; I Woldman; R Moriggl; J Hofmann; J C Marine; J N Ihle; H Beug; T Decker
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

4.  Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation.

Authors:  Katrin Friedbichler; Marc A Kerenyi; Boris Kovacic; Geqiang Li; Andrea Hoelbl; Saliha Yahiaoui; Veronika Sexl; Ernst W Müllner; Sabine Fajmann; Sabine Cerny-Reiterer; Peter Valent; Hartmut Beug; Fabrice Gouilleux; Kevin D Bunting; Richard Moriggl
Journal:  Blood       Date:  2010-05-27       Impact factor: 22.113

Review 5.  The biological functions of the versatile transcription factors STAT3 and STAT5 and new strategies for their targeted inhibition.

Authors:  Sylvane Desrivières; Christian Kunz; Itamar Barash; Vida Vafaizadeh; Corina Borghouts; Bernd Groner
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-01       Impact factor: 2.673

6.  Direct glucocorticoid receptor-Stat5 interaction in hepatocytes controls body size and maturation-related gene expression.

Authors:  David Engblom; Jan-Wilhelm Kornfeld; Lukas Schwake; Francois Tronche; Andreas Reimann; Hartmut Beug; Lothar Hennighausen; Richard Moriggl; Günther Schütz
Journal:  Genes Dev       Date:  2007-05-15       Impact factor: 11.361

Review 7.  Advances in the understanding of cytokine signal transduction: the role of Jaks and STATs in immunoregulation and the pathogenesis of immunodeficiency.

Authors:  J J O'Shea; L D Notarangelo; J A Johnston; F Candotti
Journal:  J Clin Immunol       Date:  1997-11       Impact factor: 8.317

8.  Specific DNA binding of Stat5, but not of glucocorticoid receptor, is required for their functional cooperation in the regulation of gene transcription.

Authors:  E Stoecklin; M Wissler; R Moriggl; B Groner
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

9.  Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells.

Authors:  R Moriggl; S Berchtold; K Friedrich; G J Standke; W Kammer; M Heim; M Wissler; E Stöcklin; F Gouilleux; B Groner
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

Review 10.  Molecular mechanisms of hormone controlled gene expression in the breast.

Authors:  L Hennighausen
Journal:  Mol Biol Rep       Date:  1997-08       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.